Kondás J, Szentgyörgyi E, Szecsö L, Kondér G
Department of Urologic Surgery, Municipal Péterfy Sándor Street Hospital and Outpatient Clinic, Budapest, Hungary.
Int Urol Nephrol. 1991;23(5):441-7. doi: 10.1007/BF02583987.
A total of 126 patients, whose superficial bladder tumours (Ta-Tl) had been removed by TUR, were subjected to local BCG therapy. Marked by frequent though mild side effects, they presented a significantly lower rate of tumour recurrence than the control group under exclusive TUR treatment. During a follow-up period of 3 years, 74% of the patients proved recurrence-free. BCG and Adriamycin were found largely similar in degree of effectiveness.
共有126例经尿道切除术切除浅表膀胱肿瘤（Ta-T1）的患者接受了局部卡介苗治疗。尽管副作用轻微但频繁出现，与单纯经尿道切除术治疗的对照组相比，他们的肿瘤复发率显著降低。在3年的随访期内，74%的患者无复发。发现卡介苗和阿霉素的有效性程度大致相似。
